166 related articles for article (PubMed ID: 6288415)
1. Comparison of angiotensin converting enzyme inhibitors captopril and MK421-diacid in guinea pig atria.
Nakashima A; Angus JA; Johnston CI
Eur J Pharmacol; 1982 Jul; 81(3):487-92. PubMed ID: 6288415
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid.
Reynolds CH
Biochem Pharmacol; 1984 Apr; 33(8):1273-6. PubMed ID: 6324821
[TBL] [Abstract][Full Text] [Related]
3. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
4. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
6. Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria.
Ziogas J; Story DF; Rand MJ
Eur J Pharmacol; 1984 Oct; 106(1):11-8. PubMed ID: 6099265
[TBL] [Abstract][Full Text] [Related]
7. Chronotropic effects of angiotensin I, angiotensin II, bradykinin and vasopressin in guinea pig atria.
Nakashima A; Angus JA; Johnston CI
Eur J Pharmacol; 1982 Jul; 81(3):479-85. PubMed ID: 6749532
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria.
Tesfamariam B; Allen GT; Powell JR
Eur J Pharmacol; 1995 Jul; 281(1):17-20. PubMed ID: 8566111
[TBL] [Abstract][Full Text] [Related]
9. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.
Natoff IL; Nixon JS; Francis RJ; Klevans LR; Brewster M; Budd J; Patel AT; Wenger J; Worth E
J Cardiovasc Pharmacol; 1985; 7(3):569-80. PubMed ID: 2410692
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
Gubert S; Braso MA; Sacristán A; Ortiz JA
Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor.
Sybertz EJ; Baum T; Ahn HS; Nelson S; Eynon E; Desiderio DM; Pula K; Becker F; Sabin C; Moran R; Vander Vliet G; Kastner B; Smith E
J Cardiovasc Pharmacol; 1983; 5(4):643-54. PubMed ID: 6193364
[TBL] [Abstract][Full Text] [Related]
12. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
[TBL] [Abstract][Full Text] [Related]
13. Decreased vascular responsiveness produced by angiotensin-converting enzyme inhibitors in the rat isolated kidney.
Chiba S; Quilley CP; McGiff JC
Hypertension; 1982; 4(3 Pt 2):80-5. PubMed ID: 6175573
[TBL] [Abstract][Full Text] [Related]
14. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
[No Abstract] [Full Text] [Related]
15. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
Cohen ML; Kurz KD
J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
[No Abstract] [Full Text] [Related]
16. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
Unger T; Ganten D; Lang RE; Schölkens BA
J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat.
Unger T; Schüll B; Rascher W; Lang RE; Ganten D
Biochem Pharmacol; 1982 Oct; 31(19):3063-70. PubMed ID: 6293506
[No Abstract] [Full Text] [Related]
18. Influence of the converting enzyme inhibitors Hoe 498, enalapril and captopril on vascular reactivity of isolated arterial preparations.
Schölkens BA; Xiang JZ; Tilly H
Clin Exp Hypertens A; 1984; 6(10-11):1807-13. PubMed ID: 6099766
[No Abstract] [Full Text] [Related]
19. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
Bünning P
Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
